Table 1.
Patient characteristics.
| non-recurrence group（n = 112） | recurrence group（n = 86） | Statistics value | P value | |
|---|---|---|---|---|
| Age (years) | 42 (34–48) | 41 (35–48) | −0.263 | 0.793 |
| Sex (male/female) | 89/23 | 62/24 | 1.460 | 0.227 |
| BMI (kg/m2) | 25.67 ± 2.94 | 26.16 ± 3.33 | −1.085 | 0.279 |
| LOS (day) | 10 (8–15) | 9.5 (8–16) | −0.348 | 0.728 |
| Smoking index (pack-years) | 1.75 (0–10) | 5 (0–20) | −0.944 | 0.345 |
| Alcohol abuse (n/%) | 30/26.8 | 39/45.3 | 7.383 | 0.007 |
| Hypertension (n/%) | 19/17.0 | 11/12.9 | 0.606 | 0.436 |
| Fatty liver (n/%) | 85/77.3 | 64/74.4 | 0.216 | 0.642 |
| Diabetes mellitus (n/%) | 54/48.2 | 41/47.7 | 0.006 | 0.940 |
| TG (mmol/L) | 11.60 (8.11–18.97) | 16.53 (12.90–19.47) | −3.562 | <0.001 |
| TC (mmol/L) | 7.58 (5.52–10.86) | 8.74 (6.93–11.59) | −2.242 | 0.025 |
| VLDL (mmol/L) | 4.68 (2.64–7.07) | 4.76 (2.78–7.00) | −0.579 | 0.562 |
| LDL (mmol/L) | 1.33 (0.84–2.90) | 1.57 (0.81–5.36) | −1.337 | 0.181 |
| HDL (mmol/L) | 0.71 (0.55–0.93) | 0.75 (0.53–1.08) | −0.737 | 0.461 |
| NHDL (mmol/L) | 6.95 (4.63–9.81) | 7.97 (5.98–10.39) | −2.505 | 0.012 |
| Lipoprotein a (mg/L) | 22.20 (11.10–72.30) | 24.95 (9.85–109.98) | −0.120 | 0.904 |
| Apolipoprotein A1 (g/L) | 0.98 ± 0.29 | 0.85 ± 0.33 | 2.799 | 0.006 |
| Apolipoprotein B (g/L) | 0.61 (0.38–0.79) | 0.52 (0.24–0.76) | −1.273 | 0.203 |
| FBG (mmol/L) | 11.85 (7.01–14.94) | 10.71 (7.50–15.89) | −0.081 | 0.935 |
| AST (U/L) | 33.00 (25.00–41.20) | 27.50 (21.00–45.03) | −0.870 | 0.384 |
| ALT (U/L) | 27.00 (17.00–42.56) | 21.00 (13.23–36.50) | −1.764 | 0.078 |
| Total bilirubin (umol/L) | 18.75 (13.00–24.08) | 15.60 (12.40–24.05) | −1.136 | 0.256 |
| Direct bilirubin (umol/L) | 4.65 (2.70–5.75) | 3.90 (2.08–7.31) | −0.264 | 0.792 |
| Indirect bilirubin (umol/L) | 14.90 (9.90–18.78) | 11.80 (8.48–16.63) | −1.872 | 0.061 |
| Uric acid (umol/L) | 379.65 (294.63–484.58) | 368.45 (306.08–476.30) | −0.100 | 0.920 |
| Urea (mmol/L) | 4.25 (3.20–5.38) | 4.74 (3.90–5.45) | −1.538 | 0.124 |
| Creatinine (umol/L) | 56.30 (43.33–65.35) | 53.50 (33.13–66.33) | −1.549 | 0.121 |
| WBC ( × 109/L) | 15.63 ± 5.60 | 14.47 ± 4.24 | 1.655 | 0.100 |
| Neut | 85.30 (82.50–88.08) | 86.30 (82.88–89.63) | −1.514 | 0.130 |
| Albumin (g/L) | 44.20 (40.50–47.78) | 43.60 (38.98–46.40) | −1.405 | 0.160 |
| CRP (mg/L) | 59.95 (16.17–119.42) | 39.68 (15.11–79.29) | −2.550 | 0.011 |
| Amylopsin (U/L) | 204 (125–420.23) | 184.50 (85.20–401.78) | −1.083 | 0.279 |
| Amylase (U/L) | 294.85 (167.10–527.00) | 244.05 (117.75–485.68) | −1.255 | 0.210 |
| Lipase (U/L) | 458.25 (237.00–979.43) | 467.15 (154.00–740.20) | −1.496 | 0.135 |
| Severity (non-severe/severe) | 81/31 | 68/18 | 1.190 | 0.275 |
| Necrosis (n/%) | 25/22.3 | 24/27.9 | 0.815 | 0.367 |
Bold values are statistically significant.
BMI，body mass index; LOS，length of hospital stay; TG，Triglycerides; TC，total cholesterol; VLDL，very low density lipoprotein; LDL，low density lipoprotein; HDL，high density lipoprotein; NHDL，non high-density lipoprotein; FBG，fasting blood glucose; AST，aspartate transaminase; ALT，alanine transaminase; CRP，C-reactive protein; NEUT，percentage of neutrophils.